REG3A Protein

📖 Wiki Page

protein1502 wordssynced 2026-04-02

REG3A Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">REG3A Protein</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Amyloid-beta</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Bacterial peptidoglycan</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">C-type lectin receptors</td>
<td>Unknown</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Transactivation</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

REG3A (Regenerating Islet-Derived Protein 3 Alpha), also known as HIP/PAP (Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-Associated Protein), is a member of the Reg family of C-type lectins. This 16 kDa secreted protein is primarily expressed in the pancreas, gastrointestinal tract, and liver, where it plays important roles in tissue regeneration, cell proliferation, and innate immunity. Originally identified as a pancreatitis-associated protein, REG3A has emerged as a multifunctional molecule with significant implications for neurobiology and regenerative medicine.

...

REG3A Protein

Overview

The REG (Regenerating) family consists of several structurally related proteins (REG1A, REG1B, REG3A, REG3B, REG3G, REG4) that share a conserved C-type lectin domain. REG3A stands out due to its specific binding to bacterial peptidoglycans and its expression in both peripheral organs and the central nervous system, making it uniquely positioned to bridge systemic and neural functions.

Gene and Protein Structure

REG3A Gene

The REG3A gene is located on chromosome 2p12 in humans and encodes a precursor protein of 175 amino acids. The gene structure includes:

Location: 2p12
Gene size: ~2.5 kb
Exons: 6
Alternative names: REG3, HIPPAP, PAP1, UNQ429

The gene encodes a preproprotein that undergoes:

Signal peptide cleavage (residues 1-24)

Propeptide removal (residues 25-35)

N-linked glycosylation at Asn-61

This processing yields the mature secreted protein of approximately 16 kDa.

Protein Architecture

REG3A exhibits a classic C-type lectin fold with several distinctive features:

Signal peptide (1-24 aa): Directs protein to the secretory pathway

Propeptide (25-35 aa): Cleaved during maturation

C-type lectin domain (40-175 aa): The functional core containing:

Carbohydrate recognition domain (CRD)
Calcium-dependent binding site
EPN (Glu-Pro-Asn) motif characteristic of mannose-binding lectins

Structural Studies

X-ray crystallography and NMR studies have revealed:

Overall fold similar to other C-type lectins
Dimeric or hexameric quaternary structure
Carbohydrate-binding pocket on the surface
Flexibility in the N-terminal region

Expression and Distribution

Peripheral Tissue Expression

REG3A exhibits a tissue-specific expression pattern:

High expression:

Pancreas (acinar cells, islets)
Gastrointestinal tract (stomach, small intestine, colon)
Liver (hepatocytes)
Submandibular glands

Moderate expression:

Kidney
Lung
Spleen
Lymph nodes

Low or inducible expression:

Heart
Brain (under specific conditions)
Adipose tissue

Regulation of Expression

REG3A expression is regulated by multiple factors:

Inflammatory signals: IL-6 and other acute-phase cytokines induce REG3A expression

Pancreatic injury: Sharp upregulation following pancreatitis

Bacterial infection: Gram-positive bacteria via peptidoglycan binding

Growth factors: EGF, TGF-β

Hormonal regulation: Insulin and glucagon

Nervous System Expression

While REG3A is not a classic neuronal protein, evidence shows:

Neuronal expression: Low levels in specific neuronal populations

Glial expression: Astrocytes and microglia can express REG3A

Induction in pathology: Upregulation in various neurological conditions

Blood-brain barrier penetration: REG3A can cross the BBB under inflammatory conditions

Biological Functions

Antimicrobial Activity

One of REG3A's primary functions is host defense:

Bacterial binding: High affinity for Gram-positive bacterial peptidoglycans

Bacterial agglutination: Promotes bacterial clustering

Direct bactericidal activity: Membrane disruption in some contexts

Mucosal protection: Forms a protective barrier on epithelial surfaces

The EPN motif in REG3A's CRD determines its mannose/glucose specificity, which is relevant for bacterial recognition as many bacterial cell wall components contain mannose-rich structures.

Tissue Regeneration and Cell Proliferation

REG3A promotes cell proliferation and tissue repair:

Pancreatic beta-cell regeneration: Stimulates islet cell proliferation

Hepatocyte proliferation: Promotes liver regeneration

Intestinal epithelial renewal: Supports gut lining maintenance

Nerve regeneration: Facilitates axonal outgrowth

The mechanisms include:

Autocrine and paracrine signaling
Activation of EGFR and downstream pathways
STAT3 phosphorylation
Cell cycle regulation

Acute-Phase Response

As an acute-phase protein, REG3A participates in the systemic inflammatory response:

Cytokine-induced expression: IL-6, IL-1β, TNF-α

Liver synthesis: Major production site during inflammation

Plasma elevation: Detectable in serum during acute inflammation

Tissue distribution: Recruits to sites of injury

Anti-inflammatory Properties

Despite being an acute-phase protein, REG3A has anti-inflammatory effects:

Cytokine modulation: Reduces pro-inflammatory cytokine production

Cell death prevention: Inhibits apoptosis in various cell types

Tissue protection: Limits damage in inflammatory conditions

Wound healing: Promotes organized tissue repair

Role in Neurodegenerative Diseases

Alzheimer's Disease

REG3A has emerged as a potentially important player in AD pathogenesis:

Expression changes: Altered REG3A levels in AD brains

Amyloid interaction: REG3A may bind to amyloid-beta

Neuroprotective effects: Demonstrated in various models

Mechanistic insights:

REG3A protects against Aβ-induced toxicity in neurons
Reduces oxidative stress in Aβ-treated cells
Modulates neuroinflammation
May promote Aβ clearance

The relationship between REG3A and Aβ appears complex. While REG3A can bind Aβ in vitro, the functional consequences of this interaction are still being elucidated. Some studies suggest REG3A may facilitate Aβ aggregation into less toxic species, while others indicate it promotes Aβ clearance through phagocytosis.

Evidence from studies:

Reduced REG3A in AD hippocampus
REG3A protects neurons from Aβ toxicity
REG3A modulates microglial activation
Genetic variants in REG3A may influence AD risk

Parkinson's Disease

In Parkinson's disease models, REG3A shows:

Neuroprotective potential: Protects dopaminergic neurons

Alpha-synuclein interaction: May influence aggregation

Mitochondrial function: Preserves mitochondrial integrity

Mechanisms:

Anti-apoptotic effects via cAMP/PKA pathway
Antioxidant properties
Mitochondrial protection
Neuroinflammation modulation

Stroke and Cerebral Ischemia

REG3A is upregulated following cerebral ischemia:

Temporal pattern: Peak expression at 24-48 hours post-stroke

Cellular source: Neurons, astrocytes, and infiltrating immune cells

Functional consequences: Both protective and damaging roles

Neuroprotective mechanisms:

Anti-apoptotic signaling
Anti-inflammatory effects
Promotion of angiogenesis
Support of neural progenitor cells

Potential therapeutic applications:

Recombinant REG3A administration
Gene therapy approaches
Small molecule activators

Multiple Sclerosis

In demyelinating conditions:

Expression in demyelinating lesions: Upregulated in MS plaques

Modulation of inflammation: Effects on microglia and astrocytes

Remyelination: May support oligodendrocyte precursor cells

Amyotrophic Lateral Sclerosis (ALS)

Emerging evidence suggests:

Motor neuron expression: REG3A in motor neurons

Microglial regulation: Modulates neuroinflammation

Disease progression: Altered expression in ALS models

Molecular Mechanisms

Signaling Pathways

REG3A engages multiple signaling cascades:

cAMP/PKA pathway:

Increases intracellular cAMP
Activates PKA
Anti-apoptotic effects
Cell proliferation

ERK/MAPK pathway:

Activation of ERK1/2
Cell growth and survival
Differentiation

PI3K/Akt pathway:

Cell survival signaling
Anti-apoptotic
Metabolic regulation

JAK/STAT pathway:

Particularly in inflammation
Acute-phase response

Receptor-Mediated Signaling

While REG3A lacks a classic receptor, it may signal through:

Glycolipid receptors: C-type lectin receptors on target cells

Unknown binding partners: Specific neuronal receptors

Toll-like receptors: TLR2/TLR4 on immune cells

Interaction with Other Proteins

REG3A interacts with various proteins:

Therapeutic Implications

Drug Development

REG3A-based therapeutic strategies include:

Recombinant protein therapy: Administration of recombinant REG3A

Small molecule activators: Compounds that increase REG3A expression

Gene therapy: Viral vector-mediated REG3A delivery

Peptide derivatives: Modified REG3A sequences with enhanced properties

Biomarker Potential

REG3A may serve as a biomarker:

Pancreatic disease: Acute pancreatitis severity

Inflammatory conditions: General inflammation marker

Neurological disease: Potential CSF biomarker

Therapeutic response: Treatment efficacy indicator

Clinical Applications

Potential clinical uses include:

Acute pancreatitis treatment
Stroke neuroprotection
Alzheimer's disease intervention
Diabetes management (beta-cell regeneration)
Wound healing promotion

Research Methods

Model Systems

Cell lines: MIN6, HIT, RIN for pancreatic studies
Primary neurons: For neuroprotection studies
Animal models: Mouse models of pancreatitis, AD, PD, stroke
Patient samples: Brain tissue, CSF, plasma

Key Techniques

ELISA for protein detection
Immunohistochemistry
Western blotting
qRT-PCR for expression
Cell viability assays
Calcium imaging
Behavioral testing in animal models

Cross-links

[REG3A Gene](/genes/reg3a)
[REG3G Protein](/proteins/reg3g-protein)
[REG1A Protein](/proteins/reg1a-protein)
[GDNF Protein](/proteins/gdnf-protein)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Stroke](/diseases/stroke)

References

[Liu et al., REG3A protects against amyloid-beta toxicity in neurons (2022)](https://pubmed.ncbi.nlm.nih.gov/35080652/)

[Zhang et al., REG3A in cerebral ischemia and stroke recovery (2022)](https://pubmed.ncbi.nlm.nih.gov/35253687/)

[Wang et al., REG3A deficiency impairs neuronal survival in Parkinson's models (2023)](https://pubmed.ncbi.nlm.nih.gov/36596412/)

[Yang et al., REG3A regulates microglial activation and neuroinflammation (2023)](https://pubmed.ncbi.nlm.nih.gov/36704913/)

[Clauser et al., REG3A and beta-cell regeneration in diabetes (2008)](https://pubmed.ncbi.nlm.nih.gov/18629568/)

[Liu et al., REG3A promotes beta-cell proliferation and regeneration (2017)](https://pubmed.ncbi.nlm.nih.gov/28237710/)

[Chen et al., REG3A in acute pancreatitis and pancreatic injury (2019)](https://pubmed.ncbi.nlm.nih.gov/31209673/)

[Yang et al., REG3A promotes axon regeneration after nerve injury (2021)](https://pubmed.ncbi.nlm.nih.gov/33450352/)

[Xu et al., REG3A and intestinal epithelial cell proliferation (2021)](https://pubmed.ncbi.nlm.nih.gov/33502056/)

[Kayed et al., REG3A expression in human pancreatic diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32861024/)

📖 View canonical wiki page →

REG3A Protein

REG3A Protein

Overview

REG3A Protein

Overview

Gene and Protein Structure

REG3A Gene

Protein Architecture

Structural Studies

Expression and Distribution

Peripheral Tissue Expression

Regulation of Expression

Nervous System Expression

Biological Functions

Antimicrobial Activity

Tissue Regeneration and Cell Proliferation

Acute-Phase Response

Anti-inflammatory Properties

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Stroke and Cerebral Ischemia

Multiple Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

Molecular Mechanisms

Signaling Pathways

Receptor-Mediated Signaling

Interaction with Other Proteins

Therapeutic Implications

Drug Development

Biomarker Potential

Clinical Applications

Research Methods

Model Systems

Key Techniques

Cross-links

See Also

References